DK1594526T3 - Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse - Google Patents

Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse

Info

Publication number
DK1594526T3
DK1594526T3 DK04713307T DK04713307T DK1594526T3 DK 1594526 T3 DK1594526 T3 DK 1594526T3 DK 04713307 T DK04713307 T DK 04713307T DK 04713307 T DK04713307 T DK 04713307T DK 1594526 T3 DK1594526 T3 DK 1594526T3
Authority
DK
Denmark
Prior art keywords
wound healing
hsp20
scarring
reduction
promote wound
Prior art date
Application number
DK04713307T
Other languages
English (en)
Inventor
Colleen Brophy
Alyssa Panitch
Catherine Parmiter
Elizabeth Furnish
Padmini Komalavilas
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Application granted granted Critical
Publication of DK1594526T3 publication Critical patent/DK1594526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
DK04713307T 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse DK1594526T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44895403P 2003-02-21 2003-02-21
US51221103P 2003-10-17 2003-10-17
US53030603P 2003-12-16 2003-12-16

Publications (1)

Publication Number Publication Date
DK1594526T3 true DK1594526T3 (da) 2006-11-13

Family

ID=32931323

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06014290.8T DK1808179T3 (da) 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremme af sårheling og/eller til formindskelse af ardannelse
DK04713307T DK1594526T3 (da) 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06014290.8T DK1808179T3 (da) 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremme af sårheling og/eller til formindskelse af ardannelse

Country Status (9)

Country Link
US (3) US8101572B2 (da)
EP (2) EP1594526B1 (da)
AT (2) ATE332703T1 (da)
AU (1) AU2004216241B2 (da)
DE (2) DE602004025300D1 (da)
DK (2) DK1808179T3 (da)
ES (2) ES2268631T3 (da)
PT (1) PT1808179E (da)
WO (1) WO2004075914A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075914A1 (en) 2003-02-21 2004-09-10 Arizona Board Of Regents Methods for promoting wound healing and/or reducing scar formation
CA2542639A1 (en) 2003-10-17 2005-04-28 Arizona Board Of Regents Novel heat shock protein 20-related polypeptides and uses therefor
SG173369A1 (en) * 2006-07-12 2011-08-29 Univ Arizona Methods for treating and limiting fibrotic disorders and keloids
DK2617431T3 (da) * 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptidinhibitorer af HSP27-kinase og anvendelser derfor
WO2009021137A2 (en) 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
US9327008B2 (en) 2008-12-10 2016-05-03 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
WO2011017132A2 (en) 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
US20220127313A1 (en) * 2019-02-12 2022-04-28 Vanderbilt University Polypeptides for restoring endothelial function and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280038A (en) 1992-03-13 1994-01-18 Virginia Commonwealth University Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome
US5985635A (en) 1996-11-15 1999-11-16 Incyte Pharmaceuticals, Inc. Nucleic acids encoding novel human serine/threonine protein kinases
US6475490B1 (en) 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
AU2001249214A1 (en) 2000-03-15 2001-09-24 The Brigham And Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
JP2001278894A (ja) 2000-03-29 2001-10-10 Osamu Ozawa 血液循環障害予防および／または治療用医薬用組成物並びにその有効成分であるペプチド
EP1294871A1 (en) * 2000-06-21 2003-03-26 Amgen, Inc. Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
WO2003018758A2 (en) 2001-08-23 2003-03-06 Arizona Board Of Regents Reagents and methods for smooth muscle therapies
AU2003260668A1 (en) 2002-04-01 2003-10-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Biological affinity based delivery systems
WO2004017912A2 (en) 2002-08-22 2004-03-04 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University, Office Of Technology Collaboration And Licensing Methods for increasing the rate of heart muscle contraction
WO2004075914A1 (en) 2003-02-21 2004-09-10 Arizona Board Of Regents Methods for promoting wound healing and/or reducing scar formation
CA2542639A1 (en) 2003-10-17 2005-04-28 Arizona Board Of Regents Novel heat shock protein 20-related polypeptides and uses therefor

Also Published As

Publication number Publication date
ES2268631T3 (es) 2007-03-16
EP1808179B1 (en) 2010-01-20
DK1808179T3 (da) 2010-04-12
AU2004216241B2 (en) 2006-12-14
EP1808179A2 (en) 2007-07-18
ATE455553T1 (de) 2010-02-15
US20150072936A1 (en) 2015-03-12
US8765673B2 (en) 2014-07-01
AU2004216241A1 (en) 2004-09-10
US20100009903A1 (en) 2010-01-14
US20120238508A1 (en) 2012-09-20
EP1808179A3 (en) 2007-10-24
US8101572B2 (en) 2012-01-24
DE602004025300D1 (de) 2010-03-11
PT1808179E (pt) 2010-03-24
EP1594526B1 (en) 2006-07-12
EP1594526A1 (en) 2005-11-16
ATE332703T1 (de) 2006-08-15
WO2004075914A1 (en) 2004-09-10
DE602004001509D1 (de) 2006-08-24
DE602004001509T2 (de) 2007-02-15
ES2338350T3 (es) 2010-05-06

Similar Documents

Publication Publication Date Title
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
NO20062148L (no) Antistoffer som binder interleukin-4-reseptor
DK2298338T3 (da) Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
DK1287140T3 (da) Antistofmolekyler, der har specificitet overfor human tumornekrosefaktor-alfa og anvendelse deraf
DE602004028934D1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
IS2641B (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
DE60335018D1 (de) Mittel zur verhinderung von hautalterung
DK1594526T3 (da) Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
ITMI20030897A1 (it) Procedimento e apparecchiatura per frazionare sangue.
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
DE50311406D1 (de) Verwendung von Formkörpern
DE60336746D1 (de) Trimer-proteine zur trimer-zytokine
NO20041563L (no) Rensemetode for polypeptid
ATE506960T1 (de) Medikament und verwendung zur tumortherapie
ITRM20020308A1 (it) Apparecchiatura per trattamenti terapeutici, e relativo metodo.
ITRM20020307A1 (it) Apparecchiatura per il trattamento di lesioni cutanee, e relativo metodo.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
ES1053054Y (es) Controlador personal de la afinacion de gaitas.
ES1058788Y (es) Pieza para la prolongacion bifurcada de postes para la fijacion de alambres de espinos y/o concertinas.
ITMI20021205A1 (it) Uso di proteine per il trattamento della leishmaniosi
ITRN20020017U1 (it) Orologio da polso utilizzabile per difesa personale
DE60326437D1 (de) Therapeutische verwendung von sapogeninen